Navigation Links
New drug may stop alopecia

Researchers have derived a new gel to reduce the hair loss due to chemotherapy, which is one of the distressing side effects of the treatment of cancer. The pharmaceutical company Glaxo Wellcome has formulated a gel which which contains a drug known as GW8510, helped to prevent hair loss// in rats subjected to chemotherapy.

Lead researcher Stephen Davis said the gel completely prevented hair loss in half of the rats that subsequently underwent chemotherapy. No side effects were detected and the drug did not interfere with the cancer-killing effects of the treatment.

Hair falls out because chemotherapy drugs aim to kill rapidly dividing cancer cells but also hit the cells surrounding hair follicles that divide quickly. The gel works by inhibiting the action of an enzyme involved in cell division. By applying GW8510 directly to the scalp, the drug does not enter the bloodstream and affects only the hair cells and not the cancer cells.


'"/>




Page: 1

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. "Make AIDS Therapy affordable" - Physicians demand
5. Hormone replacement Therapy a headache
6. Simple Therapy
7. Therapy for stopping the spread of cancer cells
8. Gene Therapy Destroys Pancreatic Cancer Cells
9. Letrozole Beats Tamoxifen in Breast Cancer Therapy
10. Garlic Supplements Impede HIV Therapy
11. A new study surpasses Gene Therapy Hurdle

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New drug may stop alopecia

(Date:12/1/2009)... , LEHIGH VALLEY, Pa., Dec. 1 /PRNewswire-First... has completed the previously announced sale of th..., marketed under the Airthane® and Versathane...subsidiary of global polyurethane chemicals produc...roducts, manufacturing facility in Paulsboro, N.J....
(Date:12/1/2009)..., WASHINGTON, Dec. 1 ...y for International Development: ,, Chairman Ke...ittee. ,, I am honored to be nominated by Presi... States Agency for International Development, and ...cy. ,, Secretary of State Clinton has expresse...
(Date:12/1/2009)... , FORT LAUDERDALE, Fla., Dec. 1 /PRNewswire/...atient enrollment in the randomized clinical trial...nt (Combo Stent). ,, A prospective, randomized,...aluation of an ablu M inal sirolimus coat ED ...ents at up to 20 sites in Asia, Australia, Europe ...
(Date:12/1/2009)...g men who believe that happiness declines with age...rs such as binge drinking. Their misguided negativ...ive to behave ,sensibly, and encourage them to mak...rable, old age. These findings 1 by Dr. John Gar...fast, Northern Ireland, are published online in Sp...
(Date:12/1/2009)... improves diagnosis of benign versus cancerous les...1 (HealthDay News) -- When used with ultrasound, e...d benign breast lesions, which reduces unnecessary... 80 percent of breast lesions that are biopsied tu...cer Society. , "There,s a lot of room to improv...
Breaking Medicine News(10 mins):Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 2Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 4Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 5Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 6Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 7Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 8Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 9Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:Binge drinking youths find getting old a drag 2Health News:Ultrasound With Elastography May Cut Down on Biopsies 2
...nce New Institute for Mental Health,Education, CH... help families touched by the stigma of mental ill..., and Chicago School President Michael,Horowitz an...f the Cohens, daughter, who took her life in May 2...
...health trend documented over the past 30 years of ...ng as is widely perceived - and, in fact, the tren...tional data by Mayo Clinic. , This suggests that...ad researcher. , "This study may surprise people ...
... kind of heart-healthy coating, experts explain , ...ew generation of stents shows promise in avoiding ...ting stents in patients with heart disease, resear...ith an antibody that provokes cells lining artery ...
...term study of more than 14,000 physicians showed n...itamins taken by much of,the American population.,... protect against heart,and blood vessel disease., ...taken individually, according to a,long-term study...
... tailored doses of clopidogrel significantly reduc...platelet reactivity,monitoring by VASP phosphoryla...t,s anti-platelet response to clopidogrel., -- Re...clotting medication dosing significantly cut the r...
... million in savings,have been implemented in the f...stem Consortium,s (UHC) utilizing the latest enhan.... With the new, easy-to-use UHC,Interactive WorkPl...evealed by comparison to contracts offered by,Nova...
Other Medicine News:Health News:Naomi Ruth Cohen Charitable Foundation Finds New Home at The Chicago School of Professional Psychology 2Health News:Naomi Ruth Cohen Charitable Foundation Finds New Home at The Chicago School of Professional Psychology 3Health News:Past gains in reducing risk of heart disease have flattened, women especially affected 2Health News:New Type of Stent Shows Promise 2Health News:New Type of Stent Shows Promise 3Health News:New Type of Stent Shows Promise 4Health News:Two Antioxidant Vitamins Don't Protect Against Heart Disease 2Health News:Two Antioxidant Vitamins Don't Protect Against Heart Disease 3Health News:Tailored Drug Delivery Reduces Adverse Effects After PCI 2Health News:Tailored Drug Delivery Reduces Adverse Effects After PCI 3Health News:SpendLINK(TM) Enhancements Help Academic Medical Centers Easily Track Savings Opportunities 2
(Date:12/1/2009)...OSTON, Dec. 1 An expert ...RXL ), a leading global biopharmaceutical services...ive approaches to drug development in Asia at the ...rence, being held December 1-3, 2009 at the Interc...r of the conference, which is focused on maximizin...
(Date:11/30/2009)...POLIS, Nov. 30 Nonin Medical, Inc....solutions and the inventor of fingertip pulse oxim...American Product Line Strategy Award in Remote Pat...accurate remote physiological monitoring, Nonin Me...mier provider of telemedicine monitoring equipment...
(Date:11/30/2009)..., Nov. 30 DATATRAK Inter...vices company focused on global eClinical solution...d that PFC Pharma Focus AG (PFC) has joined its CR...o contract for DATATRAK,s CRO partner training and...uct suite. In addition, PFC will also have access...
Breaking Medicine Technology:PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 2PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 3PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 4Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership 2Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership 3PFC Pharma Joins DATATRAK's CRO Connect Program 2PFC Pharma Joins DATATRAK's CRO Connect Program 3PFC Pharma Joins DATATRAK's CRO Connect Program 4Nations Nursing Home Caregivers 3A Health and Well Being of Americas Most Vulnerable Seniors at Stake as Medicare Cuts Debated in Washington 57539 1Nations Nursing Home Caregivers 3A Health and Well Being of Americas Most Vulnerable Seniors at Stake as Medicare Cuts Debated in Washington 57539 2United Way of Greater Los Angeles Announces Matching Fund Launched by Two Local Philanthropists 57538 1United Way of Greater Los Angeles Announces Matching Fund Launched by Two Local Philanthropists 57538 2Health Care Reform and American Federalism 57536 1Health Care Reform and American Federalism 57536 2
...a, May 21 Today at the,World Congress of Cardiolo...ectives in Atrial Fibrillation Management" chaired... George,s University of London,highlighted the imp...al,results, as the way forward in the future manag... of cardiac arrhythmia., To view the Multimedia N...
...a expected in second half of 2008 --,-- Presentati...onference on, May 21st canceled; webcast of corpo...Stockholder Meeting on May 22nd at 9:30 a.m. PT --...daq: RDEA ) today announced that data was present...ase (MEK) inhibitor, RDEA119, demonstrating,potent...
Other Medicine Technology:ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 2ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 3ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 4ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 5ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 6Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis 2Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis 3Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis 4
Townsend
Micro Decker Rongeur
Spurling Kerrison Rongeurs
Tiemann-Brink Rongeurs
Medicine Products: